Structure |
Chemical Name |
CAS |
MF |
![2-AMINO-3,5-DIBROMOBENZENE-1-CARBOHYDRAZIDE](/CAS/GIF/97096-13-4.gif) |
2-AMINO-3,5-DIBROMOBENZENE-1-CARBOHYDRAZIDE |
97096-13-4 |
C7H7Br2N3O |
![Trityl losartan](/CAS/GIF/133909-99-6.gif) |
Trityl losartan |
133909-99-6 |
C41H37ClN6O |
![4-BROMOMETHYLBIPHEBYL-2'-CARBOXYLIC ACID](/StructureFile/ChemBookStructure7/GIF/CB4302342.gif) |
4-BROMOMETHYLBIPHEBYL-2'-CARBOXYLIC ACID |
150766-86-2 |
C14H11BrO2 |
![Letrozole Impurity](/) |
Letrozole Impurity |
|
|
![Parecoxib Impurity J](/) |
Parecoxib Impurity J |
|
|
![6-(4-(4-(benzo[b]thiophen-4-yl)piperazin-1-yl)butoxy)-1-(4-(2-oxo-1,2-dihydroquinolin-7-yloxy)butyl)quinolin-2(1H)-one](/CAS/20180702/GIF/CB43038765.gif) |
6-(4-(4-(benzo[b]thiophen-4-yl)piperazin-1-yl)butoxy)-1-(4-(2-oxo-1,2-dihydroquinolin-7-yloxy)butyl)quinolin-2(1H)-one |
|
C38H40N4O4S |
![Linagliptin Impurity J](/) |
Linagliptin Impurity J |
|
|
![Linagliptin Impurity Q](/) |
Linagliptin Impurity Q |
|
|
![(R)-2-(((1-(3-(2-cyano-5-fluorobenzyl)-1-methyl-2,6-dioxo-1,2,3,6-tetrahydropyrimidin-4-yl)piperidin-3-yl)amino)methyl)-4-fluorobenzonitrile](/CAS/20180702/GIF/CB43042201.gif) |
(R)-2-(((1-(3-(2-cyano-5-fluorobenzyl)-1-methyl-2,6-dioxo-1,2,3,6-tetrahydropyrimidin-4-yl)piperidin-3-yl)amino)methyl)-4-fluorobenzonitrile |
|
C26H24F2N6O2 |
![Rosuvastatin Calcium Impurity](/) |
Rosuvastatin Calcium Impurity |
|
|
![Canagliflozin Monoacetyl Impurity](/) |
Canagliflozin Monoacetyl Impurity |
|
|
![Etoricoxib Impurity 13](/CAS/20200611/GIF/1817735-82-2.gif) |
Etoricoxib Impurity 13 |
1817735-82-2 |
C25H20ClN3O3S |
![Mirabegron Impurity 11](/CAS/20200611/GIF/1684452-85-4.gif) |
Mirabegron Impurity 11 |
1684452-85-4 |
C21H24N4O2S |
![Riociguat Impurtiy 2](/) |
Riociguat Impurtiy 2 |
|
|
![Topiroxostat Impurity 9](/CAS/20200611/GIF/577778-82-6.gif) |
Topiroxostat Impurity 9 |
577778-82-6 |
C13H8N6O |
![Vonoprazan Impurity F](/) |
Vonoprazan Impurity F |
|
|
![Vortioxetine Impurity 15](/CAS/20210305/GIF/2099147-02-9.gif) |
Vortioxetine Impurity 15 |
2099147-02-9 |
C28H34N4S2 |
![Dapagliflozin Impurity H](/) |
Dapagliflozin Impurity H |
|
|
![Dapoxetine Impurity C](/) |
Dapoxetine Impurity C |
|
|
![Iodixanol Impurity](/) |
Iodixanol Impurity |
|
|
![Levothyroxine EP Impurity B](/CAS/20180808/GIF/1628720-66-0.gif) |
Levothyroxine EP Impurity B |
1628720-66-0 |
C15H11ClI3NO4 |
![Ribavirin Imp. EP)](/) |
Ribavirin Imp. EP) |
|
|
![Sertraline EP Impurity](/CAS/20180702/GIF/CB43050598.gif) |
Sertraline EP Impurity |
|
C17H17Cl2N |
![Vildagliptin Related Compound G](/CAS/20200515/GIF/1616662-84-0.gif) |
Vildagliptin Related Compound G |
1616662-84-0 |
C12H20N4O3 |
![3-ethyl 5-isopropyl 2-((2-aminoethoxy)methyl)-4-(2-chlorophenyl)-6-methyl-1,4-dihydropyridine-3,5-dicarboxylate](/CAS/20180702/GIF/158151-92-9.gif) |
3-ethyl 5-isopropyl 2-((2-aminoethoxy)methyl)-4-(2-chlorophenyl)-6-methyl-1,4-dihydropyridine-3,5-dicarboxylate |
158151-92-9 |
C22H29ClN2O5 |
![Methyl 3-acetamido-4-(2,4,5-trifluorophenyl)but-2-enoate](/CAS/20180703/GIF/1234321-81-3.gif) |
Methyl 3-acetamido-4-(2,4,5-trifluorophenyl)but-2-enoate |
1234321-81-3 |
C13H12F3NO3 |
![FG-4592 intermediate 8](/CAS/20200611/GIF/1509958-20-6.gif) |
FG-4592 intermediate 8 |
1509958-20-6 |
C20H17NO6 |
![Parecoxib Sodium Imp.E](/) |
Parecoxib Sodium Imp.E |
|
|
![Trelagliptin Impurity 7](/) |
Trelagliptin Impurity 7 |
|
|
![Pramipexole impurity II](/) |
Pramipexole impurity II |
|
|
![tert-butyl 4-(6-((6-acetyl-8-cyclopentyl-5-methyl-7-oxo-7,8-dihydropyrido[2,3-d]pyrimidin-2-yl)amino)pyridin-3-yl)piperazine-1-carboxylate](/CAS/20180629/GIF/1651214-74-2.gif) |
tert-butyl 4-(6-((6-acetyl-8-cyclopentyl-5-methyl-7-oxo-7,8-dihydropyrido[2,3-d]pyrimidin-2-yl)amino)pyridin-3-yl)piperazine-1-carboxylate |
1651214-74-2 |
C29H37N7O4 |
![Prasugrel Impurity 4 HCl](/CAS/20211123/GIF/1618107-96-2.gif) |
Prasugrel Impurity 4 HCl |
1618107-96-2 |
C20H22Cl2FNO3S |
![Tofacitinib Impurity K](/) |
Tofacitinib Impurity K |
|
|
![N-(3-chloro-4-fluorophenyl)-7 -methoxy-6-(3-morpholinopropoxy)-N-(3-morpholinopropyl)quinazolin-4-amine](/CAS/20180702/GIF/1502829-45-9.gif) |
N-(3-chloro-4-fluorophenyl)-7 -methoxy-6-(3-morpholinopropoxy)-N-(3-morpholinopropyl)quinazolin-4-amine |
1502829-45-9 |
C29H37ClFN5O4 |
![5-(hydroxymethyl)-1,2-dihydro-1,2,4-triazol-3-one](/CAS/20180703/GIF/24021-90-7.gif) |
5-(hydroxymethyl)-1,2-dihydro-1,2,4-triazol-3-one |
24021-90-7 |
C3H5N3O2 |
![( 2-{4-[N-(5,6-diphenylpyrazin-2-yl)-N-isopropylamino]butyloxy}acetic acid tert-butylester )](/CAS/20180702/GIF/475084-96-9.gif) |
( 2-{4-[N-(5,6-diphenylpyrazin-2-yl)-N-isopropylamino]butyloxy}acetic acid tert-butylester ) |
475084-96-9 |
C29H37N3O3 |
![N-(4-Hydroxymethylbenzyl) Cyclam](/CAS/20180702/GIF/176252-20-3.gif) |
N-(4-Hydroxymethylbenzyl) Cyclam |
176252-20-3 |
C18H32N4O |
![Alvimopan Impurity 3](/) |
Alvimopan Impurity 3 |
|
|
![Nicergoline Impurity G](/) |
Nicergoline Impurity G |
|
|
![Isavuconazole Impurity 1](/CAS/20210111/GIF/2069200-13-9.gif) |
Isavuconazole Impurity 1 |
2069200-13-9 |
C13H12F2N4O |
![Sofosbuvir Impurity23](/) |
Sofosbuvir Impurity23 |
|
|
![Tacrolimus Impurity 1](/) |
Tacrolimus Impurity 1 |
|
|
![Bisoprolol EP Impurity F](/CAS/20180703/GIF/1798418-82-2.gif) |
Bisoprolol EP Impurity F |
1798418-82-2 |
C18H31NO4 |
![Pantoprazole EP Impurity F](/CAS/20200515/GIF/721924-06-7.gif) |
Pantoprazole EP Impurity F |
721924-06-7 |
C17H17F2N3O4S |
![Rosuvastatin EP Impurity E](/) |
Rosuvastatin EP Impurity E |
|
|
![(6R,7R)-3-(((5-methyl-1,3,4-thiadiazol-2-yl)thio)methyl)-8-oxo-7-pivalamido-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid](/CAS/20180703/GIF/CB43159611.gif) |
(6R,7R)-3-(((5-methyl-1,3,4-thiadiazol-2-yl)thio)methyl)-8-oxo-7-pivalamido-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid |
1798390-48-3 |
C16H20N4O4S3 |
![(S)-ethyl 3-((R)-5-oxopyrrolidine-2-carbonyl)thiazolidine-4-carboxylate(DD)](/) |
(S)-ethyl 3-((R)-5-oxopyrrolidine-2-carbonyl)thiazolidine-4-carboxylate(DD) |
|
|
![Lincomycin EP Impurity B](/CAS/20180808/GIF/37744-65-3.gif) |
Lincomycin EP Impurity B |
37744-65-3 |
C18H32N2O6S |
![Roxithromycin EP Impurity D](/CAS/20180808/GIF/134931-00-3.gif) |
Roxithromycin EP Impurity D |
134931-00-3 |
C41H76N2O15 |
![2-(pentan-3-yloxy)acetaldehyde](/CAS/20180529/GIF/1141364-90-0.gif) |
2-(pentan-3-yloxy)acetaldehyde |
1141364-90-0 |
C7H14O2 |
![Cabozantinib Impurity B](/) |
Cabozantinib Impurity B |
|
|
![(R)-5-(2-(2,5-difluorophenyl)pyrrolidin-1-yl)pyrazolo[1,5-a]pyrimidin-3-amine](/CAS/20180529/GIF/1223404-88-3.gif) |
(R)-5-(2-(2,5-difluorophenyl)pyrrolidin-1-yl)pyrazolo[1,5-a]pyrimidin-3-amine |
1223404-88-3 |
C16H15F2N5 |
![Ceftazidime Ep Impurity H](/CAS/20180808/GIF/1354396-23-8.gif) |
Ceftazidime Ep Impurity H |
1354396-23-8 |
C23H24N6O7S2 |
![Parecoxib Sodium Impurity 14](/CAS/20200611/GIF/1709956-89-7.gif) |
Parecoxib Sodium Impurity 14 |
1709956-89-7 |
C19H18N2O4S |
![Benzoic acid, 2-[(methylamino)sulfonyl]-](/CAS/20180529/GIF/125372-22-7.gif) |
Benzoic acid, 2-[(methylamino)sulfonyl]- |
125372-22-7 |
C8H9NO4S |
![1-Piperazineethanol,4-[(2-chlorophenyl)(3-chlorophenyl)methyl]-, hydrochloride (1:2)](/CAS/20180808/GIF/126517-38-2.gif) |
1-Piperazineethanol,4-[(2-chlorophenyl)(3-chlorophenyl)methyl]-, hydrochloride (1:2) |
126517-38-2 |
C19H24Cl4N2O |
![Benzene,1-ethoxy-4-(phenylmethyl)-](/CAS/20180601/GIF/35672-52-7.gif) |
Benzene,1-ethoxy-4-(phenylmethyl)- |
35672-52-7 |
C15H16O |
![Donepezil Impurity](/CAS/20180531/GIF/36159-03-2.gif) |
Donepezil Impurity |
36159-03-2 |
C22H22O5 |
![tert-Butyl 4-(4-nitropyridin-3-yl)piperazine-1-carboxylate](/CAS/GIF/1774898-55-3.gif) |
tert-Butyl 4-(4-nitropyridin-3-yl)piperazine-1-carboxylate |
1774898-55-3 |
C14H20N4O4 |
![4-(2-Aminophenoxy)-N-methylpicolinamide](/CAS/GIF/1153328-25-6.gif) |
4-(2-Aminophenoxy)-N-methylpicolinamide |
1153328-25-6 |
C13H13N3O2 |
![Bupivacaine Impurity](/CAS/20210111/GIF/780736-98-3.gif) |
Bupivacaine Impurity |
780736-98-3 |
C14H20N2O |
![rel-(4aR,7aR)-6-Benzyloctahydro-1H-pyrrolo[3,4-b]pyridine](/CAS/20210111/GIF/161594-54-3.gif) |
rel-(4aR,7aR)-6-Benzyloctahydro-1H-pyrrolo[3,4-b]pyridine |
161594-54-3 |
C14H20N2 |
![1,2-bis(4-(3-(trifluoromethyl)phenyl)piperazin-1-yl)ethane](/CAS/20180531/GIF/51299-16-2.gif) |
1,2-bis(4-(3-(trifluoromethyl)phenyl)piperazin-1-yl)ethane |
51299-16-2 |
C24H28F6N4 |
![(R)-N-(1-(7,8-dihydronaphthalen-1-yl)ethyl)-3-(3-(trifluoromethyl)phenyl)propan-1-amine](/CAS/20180531/GIF/802918-35-0.gif) |
(R)-N-(1-(7,8-dihydronaphthalen-1-yl)ethyl)-3-(3-(trifluoromethyl)phenyl)propan-1-amine |
802918-35-0 |
C22H24F3N |
![Demiditraz racemate](/CAS/20210111/GIF/944263-08-5.gif) |
Demiditraz racemate |
944263-08-5 |
C13H16N2 |
![Ropivacaine-iPr](/CAS/20210111/GIF/175888-75-2.gif) |
Ropivacaine-iPr |
175888-75-2 |
C17H26N2O |
![Demiditraz IMpurity](/CAS/20210111/GIF/944267-48-5.gif) |
Demiditraz IMpurity |
944267-48-5 |
C19H18N2O |
![Betamethasone EP Impurity F](/CAS/20180529/GIF/330157-04-5.gif) |
Betamethasone EP Impurity F |
330157-04-5 |
C22H28O4 |
![Capecitabine Impurity 8](/) |
Capecitabine Impurity 8 |
|
|
![Carfilzomib Impurity D](/) |
Carfilzomib Impurity D |
|
|
![Cefodizime Impurity 4](/) |
Cefodizime Impurity 4 |
|
|
![Cefradine impurity 5](/CAS/20211123/GIF/1379292-16-6.gif) |
Cefradine impurity 5 |
1379292-16-6 |
C10H17NO2 |
![Clopidogrel Impurity 13](/CAS/20200119/GIF/2173294-69-2.gif) |
Clopidogrel Impurity 13 |
2173294-69-2 |
C16H16ClNO5S2 |
![DecitaBine Impurity 12](/) |
DecitaBine Impurity 12 |
|
|
![Erlotinib Impurity 28](/) |
Erlotinib Impurity 28 |
|
|
![Fosaprepitant Impurity 12](/CAS/20210305/GIF/172673-19-7.gif) |
Fosaprepitant Impurity 12 |
172673-19-7 |
C23H22F7N4O6P |
![Ibuprofen Impurity 2](/CAS/20180702/GIF/CB43359503.gif) |
Ibuprofen Impurity 2 |
|
C13H18O2 |
![Imatinib Impurity 9](/) |
Imatinib Impurity 9 |
|
|
![Isavuconazole Impurity 22](/) |
Isavuconazole Impurity 22 |
|
|
![Isavuconazole Impurity 28](/) |
Isavuconazole Impurity 28 |
|
|
![Levothyroxine Impurity 16](/CAS/20211123/GIF/909279-46-5.gif) |
Levothyroxine Impurity 16 |
909279-46-5 |
C15H11ClI3NO4 |
![Linagliptin Impurity 42](/) |
Linagliptin Impurity 42 |
|
|
![PalBociclib Impurity 25](/) |
PalBociclib Impurity 25 |
|
|
![Posaconazole Impurity 13](/CAS/20211123/GIF/357189-98-1.gif) |
Posaconazole Impurity 13 |
357189-98-1 |
C37H40F2N8O6 |
![Posaconazole Impurity 25](/CAS/20200515/GIF/1042398-26-4.gif) |
Posaconazole Impurity 25 |
1042398-26-4 |
C16H19F2IO3 |
![Posaconazole Impurity 42](/CAS/20210111/GIF/357189-96-9.gif) |
Posaconazole Impurity 42 |
357189-96-9 |
C36H40F2N8O5 |
![Posaconazole Impurity 65](/) |
Posaconazole Impurity 65 |
2947625-11-6 |
|
![Pramipexole Dimer Impurity (Mixture of Diastereomers)](/CAS/20211123/GIF/1147937-31-2.gif) |
Pramipexole Dimer Impurity (Mixture of Diastereomers) |
1147937-31-2 |
C13H23N3S |
![Sitafloxacin Impurity 1](/) |
Sitafloxacin Impurity 1 |
|
|
![Sitagliptin Impurity 25](/) |
Sitagliptin Impurity 25 |
|
|
![sofosBuvir impurity 47](/) |
sofosBuvir impurity 47 |
|
|
![SofosBuvir Impurity 64](/) |
SofosBuvir Impurity 64 |
|
|
![Tofacitinib Impurity W](/) |
Tofacitinib Impurity W |
|
|
![Trelagliptin Impurity 21](/) |
Trelagliptin Impurity 21 |
|
|
![2-chloromethyl-4-(3-hydroxypropoxy)-3-methylpyridine](/CAS/20200119/GIF/117976-92-8.gif) |
2-chloromethyl-4-(3-hydroxypropoxy)-3-methylpyridine |
117976-92-8 |
C10H14ClNO2 |
![Oxytocin Impurity 3](/) |
Oxytocin Impurity 3 |
|
|
![Rosuvastatin Impurity 158](/) |
Rosuvastatin Impurity 158 |
|
|
![Rosuvastatin Impurity 139](/) |
Rosuvastatin Impurity 139 |
|
|
![Rosuvastatin Impurity 124](/) |
Rosuvastatin Impurity 124 |
|
|
![4-(3,4-Dichlorophenyl)-1,2,3,4-Tetrahydro-](/CAS/GIF/79617-95-1.gif) |
4-(3,4-Dichlorophenyl)-1,2,3,4-Tetrahydro- |
79617-95-1 |
C17H17Cl2N |